Imatinib vs Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D
Imatinib vs Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D: Overview
This comparison examines the pharmacological differences between Imatinib and Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Pharmacokinetics
Half-life: Imatinib β 18 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O.
Molecular Weight: Imatinib β 493.6030 g/mol.
Type: Imatinib β Small molecule; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D β Vaccine component.